&nbsp;

Updated

Sep 2025

Drug

irinotecan

Other Name(s): Camptosar®

Quick Link(s):

Updated

Sep 2025

Drug

iBRUtinib

Other Name(s): Imbruvica®

Quick Link(s):

Updated

Sep 2025

Drug

pegfilgrastim

Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™

Quick Link(s):

Updated

Sep 2025

Drug

filgrastim

Other Name(s): Neupogen®, Grastofil®, Nivestym®, Nypozi®, Filra™

Quick Link(s):

Updated

Sep 2025

Drug

letrozole

Other Name(s): Femara®

Quick Link(s):

Updated

Sep 2025

Drug

lapatinib

Other Name(s): Tykerb®

Quick Link(s):

Updated

Sep 2025

Regimen

BLIN

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Palliative

Funding:

New Drug Funding Program

Blinatumomab - Relapsed or Refractory Acute Lymphoblastic Leukemia (Ph+ BCP-ALL)

New Drug Funding Program

Blinatumomab - Relapsed or Refractory Acute Lymphoblastic Leukemia (Ph- BCP-ALL)

Drugs Used:

blinatumomab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

BLIN

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

New Drug Funding Program

Blinatumomab - Minimal Residual Disease (MRD)-Positive B-cell Precursor Acute Lymphoblastic Leukemia

Drugs Used:

blinatumomab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

BLIN

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative, Palliative

Drugs Used:

blinatumomab (Compassionate)

Quick Link(s):

Regimen Monograph

Sep 2025

Drug

elranatamab

Other Name(s): Elrexfio™

Quick Link(s):

Updated

Sep 2025

Regimen

ELRA; ELRA(RAMP)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Drugs Used:

elranatamab (Compassionate)